Xenon Pharmaceuticals (XENE) insider trading in the last 6 months

2 insiders bought $1.7M, 1 sold $641K.

Quality Score-1Poor

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 3 tradesSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

BuyIan Mortimer$1.1MPresident & CEOat $37.38 on Sep 30, filed Oct 1

BuyIan MortimerPresident & CEO$1.1Mat $37.38 on Sep 30, filed Oct 1

BuyThomas Patrick Kelly$560KChief Financial Officerat $37.32 on Sep 30, filed Oct 1

BuyThomas Patrick KellyChief Financial Officer$560Kat $37.32 on Sep 30, filed Oct 1

SellSteven Gannon$641KDirectorat $64.06 on Aug 11, filed Aug 13

SellSteven GannonDirector$641Kat $64.06 on Aug 11, filed Aug 13

From SEC Form 4s, the newest filed Oct 1, 2026 · Insiders have 2 business days to file a trade

Pro members see every filing on XENE with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Xenon Pharmaceuticals

Insider trades by person

Cluster buys at XENE

2 insiders bought XENE in the last 6 months: Ian Mortimer and Thomas Patrick Kelly.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about XENE's insider trades

As of Nov 9, 2026: Xenon Pharmaceuticals (XENE) has 3 insider filings on record in the last 6 months, the newest filed Oct 1, 2026. Its Quality Score is -1 (Poor). Scores as of 9:05 AM ET, 15 minutes behind.

Are XENE insiders buying or selling?

2 insiders bought $1.7M across 2 filings, and one insider sold $641K across 1 filing, in the last 6 months. The newest filing: Ian Mortimer, President & CEO, bought $1.1M on Sep 30, 2026. 2 insiders bought XENE in the last 6 months: Ian Mortimer and Thomas Patrick Kelly.

Who are XENE's biggest insider sellers?

The one insider who sold XENE in the last 6 months: Steven Gannon (Director), 1 sale.

When did an XENE insider last buy?

Ian Mortimer, President & CEO, bought XENE shares ($1.1M) on Sep 30, 2026, filed Oct 1, 2026, the newest insider buy on record.

Xenon Pharmaceuticals's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. XENE is on insider buys, Sep 28 to Oct 4, 2026.

Xenon Pharmaceuticals (XENE) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Xenon Pharmaceuticals

Cluster buys at XENE

Questions about XENE's insider trades

Every insider trade, with its stock's score.